Clinical trial · Interventional
Adaptation of a Values Assessment Tool
Values Assessment Tailored for Women With Metastatic Breast Cancer and Their Caregivers: Adaptation and Pilot Study of a Values Assessment Tool (VAsT)
NCT07068477CI-TRIAL-00115637completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary purpose of this study is to evaluate the effect of values assessment tool on patient and caregiver perception of decisional conflict, and communication with their oncology clinician.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Metastatic Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Values Assessment Tool | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Values assessment tool
- description
- Participants are assessed at baseline and every clinic visit for 3 months
- interventionNames
- Behavioral: Values Assessment Tool
Primary outcomes (3)
- measure
- Decisional engagement
- timeFrame
- Baseline and every clinic visit for 3 months
- description
- Values Assessment Tool participants will be assessed using decisional engagement, Patient-Centered Communication in Cancer Care (PCC-Ca) 36. Each item included in the PCC-Ca instrument consists of a question stem and five response options. The response options are scored from 1 to 5, with higher scores representing better communication; for example, where 1 = Never and 5 = Always. There are no reverse-scored items. Some items have a sixth "does not apply" option. This response is not scored.
- measure
- Decisional conflict
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria 1. Age ≥18 years 2. Diagnosed with metastatic breast cancer. 3. Understand and read English. 4. Receive care or anticipate receiving care at the North Carolina Cancer Hospital ambulatory cancer clinic or affiliated community cancer clinic. 5. Able to understand and participate in study procedures for length of study. Exclusion Criteria 1. All subjects meeting any of the exclusion criteria at baseline will be excluded from study participation: 2. Unable to provide consent, unable to communicate verbally. 3. Unable to understand or read English. 4. Enrolled in hospice care.
References
Publications (0)
Data not yet available
No reference posted for this study.